Clinical Trial 42459

Woodstock, GA 30189


28-day study for women experiencing acute symptoms of  urinary tract infection (UTI). This is a phase 3, randomized, double-blind study of the efficacy, tolerability, and safety of oral sulopenum etzadroxil/probenecid versus oral coprofloxacin for treatment of uncompicated urinary tract infections in adult women.

Qualified Participants Must:

• Be female
• be age 18+
• have 2 or more symptoms: urinary frequency, urinary urgency, pain or burning upon urination, suprapubic pain
• onset of symptoms within the past 24-72 hours

Qualified Participants May Receive:

Urinalysis at screening; treatment of confirmed UTI with investigational product or ciprofloxacin; compensation for time/travel

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.